BIOMAT Database Logo BIOMAT Database Logo

Studies on pneumococcal polysaccharide. II. Mechanism involved in production of immunological paralysis by type I pneumococcal polysaccharide. 1955

O K STARK

UI MeSH Term Description Entries
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D013296 Streptococcus pneumoniae A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals. Diplococcus pneumoniae,Pneumococcus
D022242 Pneumococcal Vaccines Vaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE. Pneumococcal Polysaccharide Vaccine,Pneumococcal Vaccine,Pneumovax,Pnu-Imune Vaccine,Pnu Imune Vaccine,PnuImune Vaccine,Polysaccharide Vaccine, Pneumococcal,Vaccine, Pneumococcal,Vaccine, Pneumococcal Polysaccharide,Vaccines, Pneumococcal

Related Publications

O K STARK
Studies on immunological paralysis. I. A consideration of macrophage involvement in the induction of paralysis and immunity by type II pneumococcal polysaccharide.
January 1969, Clinical and experimental immunology,
O K STARK
Type-specificity of immunological paralysis induced in mice with pneumococcal type II polysaccharide.
February 1953, Journal of bacteriology,
O K STARK
Studies on immunological paralysis. II. The detection and significance of antibod-forming cells in the spleen during immunological paralysis with type 3 pneumococcal polysaccharide.
January 1969, Clinical and experimental immunology,
O K STARK
Immunological paralysis to pneumococcal polysaccharide in man.
August 1985, Lancet (London, England),
O K STARK
Studies on immunological paralysis. VI. Thymic-independence of tolerance and immunity to type 3 pneumococcal polysaccharide.
December 1971, Cellular immunology,
O K STARK
Studies on the mechanism of the immunological paralysis induced in mice by pneumococcal polysaccharides.
January 1955, Journal of immunology (Baltimore, Md. : 1950),
O K STARK
Immunological paralysis of mice with pneumococcal polysaccharide antigens.
September 1971, Bacteriological reviews,
O K STARK
Studies on immunological paralysis. XI. A comparison of the tolerogenicity in vitro of levan and type 3 pneumococcal polysaccharide.
August 1973, European journal of immunology,
O K STARK
Studies on immunological paralysis. IV. The relative contributions of continuous antibody neutralization and central inhibition to paralysis with type 3 pneumococcal polysaccharide.
September 1971, Proceedings of the Royal Society of London. Series B, Biological sciences,
O K STARK
Studies on immunological paralysis. 3. Recirculation and antibody-neutralizing activity of 14C-labelled type 3 pneumococcal polysaccharide in paralysed mice.
October 1970, Clinical and experimental immunology,
Copied contents to your clipboard!